7-122303935-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001024613.4(FEZF1):c.503G>T(p.Gly168Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,609,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024613.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEZF1 | ENST00000442488.7 | c.503G>T | p.Gly168Val | missense_variant | 1/4 | 1 | NM_001024613.4 | ENSP00000411145.2 | ||
FEZF1 | ENST00000427185.2 | c.429+74G>T | intron_variant | 1 | ENSP00000392727.2 | |||||
FEZF1-AS1 | ENST00000428449.5 | n.278C>A | non_coding_transcript_exon_variant | 1/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000337 AC: 8AN: 237668Hom.: 0 AF XY: 0.0000310 AC XY: 4AN XY: 129126
GnomAD4 exome AF: 0.00000824 AC: 12AN: 1456902Hom.: 0 Cov.: 33 AF XY: 0.00000690 AC XY: 5AN XY: 724414
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74382
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.503G>T (p.G168V) alteration is located in exon 1 (coding exon 1) of the FEZF1 gene. This alteration results from a G to T substitution at nucleotide position 503, causing the glycine (G) at amino acid position 168 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at